Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis.
about
Conditions in subjects with rheumatic diseases: pulmonary manifestations of vasculitidesIncreased expression of Toll-like receptors by monocytes and natural killer cells in ANCA-associated vasculitisPyrexia of unknown origin and pulmonary fibrosis as a presentation of MPO-ANCA associated vasculitis.Neutrophil extracellular traps in sterile inflammation: the story after dying?Wegener's granulomatosis: a review of clinical features and an update in diagnosis and treatment.Current understanding of the pathogenesis of granulomatosis with polyangiitis (Wegener's).Granuloma in ANCA-associated vasculitides: another reason to distinguish between syndromes?The kidneys and ANCA-associated vasculitis: from pathogenesis to diagnosis.ANCA-associated vasculitis with renal involvement.Complements do not lieConcomitant drug- and infection-induced antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis with multispecific ANCA.Unusual extracardiac manifestations of isolated native tricuspid valve endocarditis.Antineutrophil Cytoplasmic Antibody Induction due to Infection: A Patient with Infective Endocarditis and Chronic Hepatitis C.Pulmonary Limited MPO-ANCA Microscopic Polyangiitis and Idiopathic Lung Fibrosis in a Patient with a Diagnosis of IgA Nephropathy.Clinical, histopathologic, and immunofluorescence findings in levamisole/cocaine-induced thrombotic vasculitis.Otolaryngologic manifestations of antineutrophil cytoplasmic antibody-associated vasculitis.Endocarditis Mimicking Crescentic Glomerulonephritis with PR3-ANCA Positivity
P2860
Q28393792-5AE37EBC-02B5-44D1-B459-3C1153B383C0Q34018969-807BD327-207E-47BF-96EB-F3382D9B267BQ38018927-77928BE5-EE8E-443E-83CA-E04EE8B90F46Q38038666-C9415163-7A2B-4479-BC14-362FD7CFCB74Q38072743-3D645212-31A2-403D-8555-117C9EA16BB0Q38125244-83F12B65-121F-4193-B633-C17CCA789879Q38146909-228673EE-DDD1-4768-9420-01C615A5E541Q38512570-0E33FED3-01D7-4818-BA30-EC16D9FD2E09Q39339897-F5525641-F903-40DE-B6F4-8A685775C880Q39555143-8D3A9F9F-CFED-4429-A16E-D9EC9413626AQ40288877-CE908C69-9BC5-4045-8690-2315CC680E0AQ40370007-EBD2CC9F-B492-47BB-A535-D238D2548E96Q40629261-5D38C068-4776-4EF1-A723-ACE3927AF4D4Q42418193-F6B872F4-48F0-4E7F-B140-2A59AD3FB666Q47979127-9823B53A-6A4C-4701-B401-1635FAC42A25Q50432736-912F1469-E577-4462-B1B8-5AFC2EC582D0Q58766119-E8FEAD08-6D44-443A-ADE2-9D3B71B19365
P2860
Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical and immunological fea ...... mic antibodies and vasculitis.
@en
Clinical and immunological fea ...... mic antibodies and vasculitis.
@nl
type
label
Clinical and immunological fea ...... mic antibodies and vasculitis.
@en
Clinical and immunological fea ...... mic antibodies and vasculitis.
@nl
prefLabel
Clinical and immunological fea ...... mic antibodies and vasculitis.
@en
Clinical and immunological fea ...... mic antibodies and vasculitis.
@nl
P2093
P1476
Clinical and immunological fea ...... mic antibodies and vasculitis.
@en
P2093
Elena Csernok
Peter Lamprecht
Wolfgang L Gross
P356
10.1097/BOR.0B013E3283323538
P577
2010-01-01T00:00:00Z